The Influence of IL-11 on Cardiac Fibrosis in Experimental Models: A Systematic Review

被引:1
作者
Braga, Yarlla Loyane Lira [1 ]
Neto, Jose Rodrigues do Carmo [1 ]
Franco, Pablo Igor Ribeiro [1 ]
Helmo, Fernanda Rodrigues [2 ]
dos Reis, Marlene Antonia [2 ]
de Oliveira, Flavia Aparecida [1 ]
Celes, Mara Rubia Nunes [1 ]
da Silva, Marcos Vinicius [3 ]
Machado, Juliana Reis [1 ,2 ,4 ]
机构
[1] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Dept Biosci & Technol, BR-74605450 Goiania, GO, Brazil
[2] Univ Fed Triangulo Mineiro, Gen Pathol, BR-38025180 Uberaba, MG, Brazil
[3] Univ Fed Triangulo Mineiro, Inst Biol & Nat Sci, Dept Microbiol Immunol & Parasitol, BR-38025180 Uberaba, MG, Brazil
[4] Univ Fed Triangulo Mineiro, Dept Gen Pathol, BR-38025180 Uberaba, MG, Brazil
关键词
interleukin-11; fibrosis; ERK1-2; pathway; IL-11; receptors; heart diseases; ISCHEMIA-REPERFUSION INJURY; INTERLEUKIN-11; TRANSCRIPTION; ACTIVATION; TARGET;
D O I
10.3390/jcdd11020065
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fibrosis is one of the main factors that impair the function of many organs. In the heart, fibrosis leads to contractile dysfunction and arrhythmias, which are important in the development of heart failure. Interleukin (IL)-11 is regulated in various heart diseases and has recently been reported to be an important cytokine in fibrosis in this organ. However, this topic has been little explored, and many questions persist. Thus, this systematic review aimed to report on possible IL-11 therapies evaluated in rodent model-induced cardiac fibrosis. Inclusion criteria were experimental in vivo studies that used different rodent models for cardiac fibrosis associated with IL-11 interventions, without year and language restrictions. The search in PubMed, Web of Science, and Embase databases was performed in October 2022. The risk of bias assessment of the studies was based on the guidelines of the SYRCLE tool, and data from the selected articles were also presented in a table as a narrative description. This review was based on eight studies in which five different interventions were used: recombinant human IL-11 (rhIL-11), anti-IL11 (X203), recombinant mouse IL-11 (rmIL-11), lentivirus (LV)-IL-11 + lutein, and anti-IL11RA (X209). Based on the included studies, the results were variable, with IL-11 overexpression inducing cardiac fibrosis, while inhibition protected against this process, preserving the function of this organ. Therefore, IL-11 stands out as a promising therapeutic target for cardiac fibrosis. However, further studies are needed to understand the mechanisms triggered by each treatment, as well as its safety and immunogenicity.
引用
收藏
页数:13
相关论文
共 46 条
  • [1] IL11 is elevated in systemic sclerosis and IL11-dependent ERK signalling underlies TGFβ-mediated activation of dermal fibroblasts
    Adami, Eleonora
    Viswanathan, Sivakumar
    Widjaja, Anissa A.
    Ng, Benjamin
    Chothani, Sonia
    Zhihao, Nevin
    Tan, Jessie
    Lio, Pei Min
    George, Benjamin L.
    Altunoglu, Umut
    Ghosh, Kakaly
    Paleja, Bhairav S.
    Schafer, Sebastian
    Reversade, Bruno
    Albani, Salvatore
    Ling, Andrea Low Hsiu
    O'Reilly, Steven
    Cook, Stuart A.
    [J]. RHEUMATOLOGY, 2021, 60 (12) : 5820 - 5826
  • [2] Inflammation and fibrosis in murine models of heart failure
    Bacmeister, Lucas
    Schwarzl, Michael
    Warnke, Svenja
    Stoffers, Bastian
    Blankenberg, Stefan
    Westermann, Dirk
    Lindner, Diana
    [J]. BASIC RESEARCH IN CARDIOLOGY, 2019, 114 (03)
  • [3] Inhaled siRNA nanoparticles targeting IL11 inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge
    Bai, Xin
    Zhao, Guolin
    Chen, Qijing
    Li, Zhongyu
    Gao, Mingzhu
    Ho, William
    Xu, Xiaoyang
    Zhang, Xue-Qing
    [J]. SCIENCE ADVANCES, 2022, 8 (25)
  • [4] Baman Jayson R, 2020, JAMA, V324, P1015, DOI 10.1001/jama.2020.13310
  • [5] Lutein attenuates angiotensin II- induced cardiac remodeling by inhibiting AP-1/IL-11 signaling
    Chen, Youming
    Wang, Lan
    Huang, Shixing
    Ke, Jiangfeng
    Wang, Qing
    Zhou, Zhiwen
    Chang, Wei
    [J]. REDOX BIOLOGY, 2021, 44
  • [6] Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation
    Cook, Stuart A.
    Schafer, Sebastian
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 71, 2020, 2020, 71 : 263 - 276
  • [7] Therapeutic Targeting of Interleukin-11 Signalling Reduces Pressure Overload-Induced Cardiac Fibrosis in Mice
    Corden, Ben
    Lim, Wei-Wen
    Song, Weihua
    Chen, Xie
    Ko, Nicole S. J.
    Su, Liping
    Tee, Nicole G. Z.
    Adami, Eleonora
    Schafer, Sebastian
    Cook, Stuart A.
    [J]. JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2021, 14 (02) : 222 - 228
  • [8] IL-11 in cardiac and renal fibrosis: Late to the party but a central player
    Corden, Benjamin
    Adami, Eleonora
    Sweeney, Mark
    Schafer, Sebastian
    Cook, Stuart A.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (08) : 1695 - 1708
  • [9] Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH
    Dong, Jinrui
    Viswanathan, Sivakumar
    Adami, Eleonora
    Singh, Brijesh K.
    Chothani, Sonia P.
    Ng, Benjamin
    Lim, Wei Wen
    Zhou, Jin
    Tripathi, Madhulika
    Ko, Nicole S. J.
    Shekeran, Shamini G.
    Tan, Jessie
    Lim, Sze Yun
    Wang, Mao
    Lio, Pei Min
    Yen, Paul M.
    Schafer, Sebastian
    Cook, Stuart A.
    Widjaja, Anissa A.
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [10] Interleukin-11: Review of molecular, cell biology, and clinical use
    Du, XX
    Williams, DA
    [J]. BLOOD, 1997, 89 (11) : 3897 - 3908